Shandong University Laiyang Jiangbo Pharmaceuticals Co, Ltd Technology Cooperation Agreement September 16, 2007Cooperation Agreement • September 28th, 2009 • Jiangbo Pharmaceuticals, Inc. • Pharmaceutical preparations
Biochemistry and Biotechnology Research Institute of Pharmaceuticals Institute of Shandong University (Party A) has great talent and technology strength and specialized in drug research and development. To better utilize all the favorable circumstances, better transform results of technology research, and provide better environments for talent training and practice, it should timely seek to cooperate with enterprises with certain advantages and fundamentals to accomplish win-win situations
Institute of Microbiology, Chinese Academy of Sciences Laiyang Jiangbo Pharmaceutical Co. Ltd Pharmaceutical Industrialization Joint Base AgreementJiangbo Pharmaceuticals, Inc. • September 28th, 2009 • Pharmaceutical preparations
Under the background of National "Eleventh Five-Year Plan" program, IMCAS actively promotes the industrialization of scientific research to utilize its own advantages adequately and implements the policy of IMCAS and the knowledge innovation project. With the foundation of continuous improved yearly production value and revenues, Laiyang Jiangbo Pharmaceutical Co. Ltd. focuses on strengthening the basic research of biomedical industrial in order to achieve a new level. Therefore, both parties reached the agreement to form the “Joint base of industrialization, Institute of Microbiology, Chinese Academy of Sciences-Laiyang Jiangbo Pharmaceutical Co. Ltd” with the formation of good cooperative research system in order to promote the further development of bio- pharmaceutical industry with the approach of joining enterprise and institute. This agreement is signed for the implementation of this cooperation.
